SoftBank Vision Fund disposes of 6,000,000 Relay Therapeutics shares for $116.4 million
RLAY•Beneficial ownership after the transaction
Following the transaction, beneficial ownership fell to 21,904,963 shares.
SoftBank Vision Fund sells 6 million Relay Therapeutics shares
SoftBank Vision Fund entities SVF Pauling (Cayman), SoftBank Vision Fund (AIV M2) and SB Investment Advisers sold 6 million Relay Therapeutics common shares.
The sale was priced at $19.4 per share on Aug. 25, 2026.




